Treatments Flashcards
Asthma step 1
SABA
Asthma step 2
SABA and low-dose ICS
Asthma step 3
SABA + low-dose ICS + LABA or med-dose ICS
Asthma step 4
Med-dose ICS + LABA
Asthma step 5
High-dose ICS + LABA
Asthma step 6
High-dose ICS + LABA + PO CS
Mild exacerbation of asthma
SABA
Moderate exacerbation of asthma
Correction of hypoxemia with supplemental oxygen
Reversal of airflow obstruction with SABA and early administration of systemic corticosteroids
Severe exacerbation of asthma
Immediate oxygen, high dose of SABA and systemic corticosteroid (IV magnesium sulfate produces a detectable improvement in airflow)
Acute bronchitis
Supportive (encourage hydration, expectorants, anti-tussives, B2 agonists)
Chronic bronchitis
1st line- bronchodilators (anticholinergics): LAA (Tiotroprium-Spiriva) + SABA + ICS
Mucolytics, prevention (vaccines), pulmonary rehab
Acute exacerbation of chronic bronchitis
1st line: 2nd gen cephalosporin
2nd line: macrolide or Bactrim
Abx indicated for elderly, IC, cough > 7 days and pt with underlying cardiopulmonary disease
Complicated acute exacerbation of chronic bronchitis
FQ (Moxifloxacin or Levofloxacin, Gemifloxacin)
Augmentin
Emphysema
Stop smoking Anticholinergic inhalers > B2 agonists SABA for acute exacerbations Abx and CS for acute exacerbations Vaccinations: pneumonia and influenza Supplemental oxygen Encourage physical activity- pulmonary rehab
Sarcoidosis
Modest maintenance dose of corticosteroids
NSAIDs for athralgias and rheumatic complaints
Refractory: Methotrexate, azathioprine, inflixamab, lung transplant
Outpatient management of bacterial pneumonia (CAP)
No recent abx: macrolide (clarithromycin or azithromycine) or doxycycline
Comorbidities, risk for drug resistance or recent abx use: respiratory FQ (moxi, gemi, levo) or a macrolide + beta-lactam (Amox HD or augmentin)
Regions of high resistance: Respiratory FQ (Moxi, gemi, levo) or macrolide + beta-lactam
Hospital acquired pneumonia
Low-risk of MRSA or MDR pathogens: Cefepime, piperacillin-tazobactam, meropenem, Levofloxacin
More severe: Vancomycin + (Cefepime or Piperacilin-tazobactam or Meropenem)
If legionella suspected, add Levo or Azithromycin
If pseudomonas, high mortality, or MDR gm-neg suspected: add Cipro, levo, or tobramycin or amikacin
Pleural effusion
Treat the underlying disease Thoracentesis Chest tube drainage Tunneled pleural catheter placement Surgical drainage Pleurodesis
Pneumothorax
If small, stable spontaneous primary pneumothorax, observe
Supplemental oxygen
Simple aspiration drainage if large or progressive primary pneumothorax
Serial CXRs every 24 hrs
With secondary, large, tension pneumo- chest tube placement
Avoid exposure to high altitudes, flying in an unpressurized aircraft and scuba diving
ARDS
Identify and treat underlying conditions
Supportive care for severe respiratory dysfunction (intubation with positive pressure ventilation and low level PEEP)
Hyaline membrane disease
Mechanical ventilation
Adminstration of exogenous surfactant
Hordeolum
External: warm compresses only
Internal: Dicloxicillin (250-500 mg q6h) + warm compresses
If CA-MRSA: TMP/SMX DS (2 tablets BID)
Macular degeneration
Refer to ophthalmology
Neovascular: photodynamic therapy, VEGF inhibitors
Atrophic: Magnifying glasses and visual aids help
Antioxidants (Vit C and E), zinc, copper, carotenoids
Optic neuritis
Referral to ophthalmology and neurology
Admit- IV methylprednisolone 250 mg QID x 3 days with oral steroid taper
Plasma exchange
Orbital cellulitis
Admit! Consults! Monitor vision status and CNS change. Broad-spectrum IV abx for GP, GN, and anaerobic organisms
Vancomycin 15-30 mg/kg IV q8-12h + ceftriaxone 2 gm IV q24h + metronidazole 1 gm IV q12h
Piperacillin/tazobactam 4.5 gm IV q8h
Pterygium
No tx for inflammation- artificial tears only
May use topical NSAIDs or weak CS (fluoromethalone or lotepredonal) BUT MD
Surgery indicated for growth that threatens the visual axis, marked induced astigmatism, or severe irritation